Tom Mjörndal

2.6k total citations
59 papers, 2.0k citations indexed

About

Tom Mjörndal is a scholar working on Toxicology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Tom Mjörndal has authored 59 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Toxicology, 11 papers in Psychiatry and Mental health and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Tom Mjörndal's work include Pharmacovigilance and Adverse Drug Reactions (10 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Pharmaceutical studies and practices (5 papers). Tom Mjörndal is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (10 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Pharmaceutical studies and practices (5 papers). Tom Mjörndal collaborates with scholars based in Sweden, Norway and United States. Tom Mjörndal's co-authors include Rune Dahlqvist, Martin Bäckström, Staffan Hägg, Olav Spigset, R. Dahlqvist, Klaus Hoeyer, Bert‐Ove Olofsson, Niels Lynöe, Rolf Adolfsson and Bengt‐Erik Wiholm and has published in prestigious journals such as Neurology, Biological Psychiatry and Journal of Applied Physiology.

In The Last Decade

Tom Mjörndal

58 papers receiving 1.9k citations

Peers

Tom Mjörndal
Ronald D. Mann United Kingdom
François Montastruc France
W.H.W. Inman United Kingdom
Janet Sultana Italy
Kenneth K. C. Man Hong Kong
Joëlle Micallef France
Emílio J. Sanz Spain
L. F. Gram Denmark
Judith A. Racoosin United States
Geneviève Durrieu France
Ronald D. Mann United Kingdom
Tom Mjörndal
Citations per year, relative to Tom Mjörndal Tom Mjörndal (= 1×) peers Ronald D. Mann

Countries citing papers authored by Tom Mjörndal

Since Specialization
Citations

This map shows the geographic impact of Tom Mjörndal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Mjörndal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Mjörndal more than expected).

Fields of papers citing papers by Tom Mjörndal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Mjörndal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Mjörndal. The network helps show where Tom Mjörndal may publish in the future.

Co-authorship network of co-authors of Tom Mjörndal

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Mjörndal. A scholar is included among the top collaborators of Tom Mjörndal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Mjörndal. Tom Mjörndal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lakso, Hans‐Åke, et al.. (2008). Urine Monitoring of Diazepam Abuse—New Intake or Not?. Journal of Analytical Toxicology. 32(6). 402–407. 8 indexed citations
2.
Asplund, Christopher L., et al.. (2007). Serum Levels of Olanzapine in a Non-Fatal Overdose. Journal of Analytical Toxicology. 31(2). 119–121. 8 indexed citations
3.
Hägg, Staffan, et al.. (2006). High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia. International Clinical Psychopharmacology. 21(2). 93–98. 119 indexed citations
4.
Hoeyer, Klaus, Bert‐Ove Olofsson, Tom Mjörndal, & Niels Lynöe. (2005). The Ethics of Research Using Biobanks. Archives of Internal Medicine. 165(1). 97–97. 88 indexed citations
5.
Bäckström, Martin, Tom Mjörndal, & R. Dahlqvist. (2004). Under‐reporting of serious adverse drug reactions in Sweden. Pharmacoepidemiology and Drug Safety. 13(7). 483–487. 104 indexed citations
6.
Mjörndal, Tom, et al.. (2004). Sepsis as a Possible Adverse Drug Reaction in Patients With Rheumatoid Arthritis Treated With TNFα Antagonists. JCR Journal of Clinical Rheumatology. 10(3). 119–122. 16 indexed citations
7.
Wihlbäck, Anna‐Carin, Inger Sundström Poromaa, Marie Bixo, et al.. (2003). Influence of menstrual cycle on platelet serotonin uptake site and serotonin2A receptor binding. Psychoneuroendocrinology. 29(6). 757–766. 40 indexed citations
8.
Persson, Mats, et al.. (2002). 1999 WHO/ISH Guidelines applied to a 1999 MONICA sample from northern Sweden. Journal of Hypertension. 20(1). 29–35. 35 indexed citations
9.
Mjörndal, Tom, Staffan Hägg, Martin Bäckström, et al.. (2002). Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiology and Drug Safety. 11(1). 65–72. 165 indexed citations
10.
Bäckström, Martin, Staffan Hägg, Tom Mjörndal, & R. Dahlqvist. (2002). Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis. Pharmacoepidemiology and Drug Safety. 11(3). 239–245. 34 indexed citations
11.
12.
Hägg, Staffan, Olav Spigset, Tom Mjörndal, & Rune Dahlqvist. (2000). Effect of caffeine on clozapine pharmacokinetics in healthy volunteers. British Journal of Clinical Pharmacology. 49(1). 59–63. 50 indexed citations
13.
Spigset, Olav, et al.. (2000). Serotonin 5-HT2A Receptor Binding in Platelets From Patients With Alzheimer's Disease or Vascular Dementia. International Psychogeriatrics. 12(4). 537–545. 7 indexed citations
14.
Smedh, Kenneth, Olav Spigset, Per Allard, Tom Mjörndal, & Rolf Adolfsson. (1999). Platelet [3H]paroxetine and [3H]lysergic acid diethylamide binding in seasonal affective disorder and the effect of bright light therapy. Biological Psychiatry. 45(4). 464–470. 21 indexed citations
15.
Hägg, Staffan, et al.. (1999). Absence of interaction between erythromycin and a single dose of clozapine. European Journal of Clinical Pharmacology. 55(3). 221–226. 31 indexed citations
16.
17.
Spigset, Olav & Tom Mjörndal. (1997). The Effect of Fluvoxamine on Serum Prolactin and Serum Sodium Concentrations. Journal of Clinical Psychopharmacology. 17(4). 292–297. 30 indexed citations
18.
Spigset, Olav & Tom Mjörndal. (1997). Effect of fluvoxamine on platelet 5-HT 2A receptors as studied by [ 3 H]lysergic acid diethylamide ([ 3 H]LSD) binding in healthy volunteers. Psychopharmacology. 133(1). 39–42. 10 indexed citations
19.
Cassel, Gudrun, et al.. (1993). Effects of cyanide on the striatal dopamine receptor binding in the rat. European Journal of Pharmacology Environmental Toxicology and Pharmacology. 248(4). 297–301. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronald D. Mann Breakdown of academic impact, for papers by François Montastruc Breakdown of academic impact, for papers by W.H.W. Inman Breakdown of academic impact, for papers by Janet Sultana Breakdown of academic impact, for papers by Kenneth K. C. Man Breakdown of academic impact, for papers by Joëlle Micallef Breakdown of academic impact, for papers by Emílio J. Sanz Breakdown of academic impact, for papers by L. F. Gram Breakdown of academic impact, for papers by Judith A. Racoosin Breakdown of academic impact, for papers by Geneviève Durrieu
Rankless by CCL
2026